In MLL-driven AML, elevated JMJD2C levels increase expression of pro-proliferative targets, among them Myc, Hoxa9, and Meis1 [12], while increased JMJD2C activity in JAK2V617F-positive HEL cells prevents cellular senescence [13]. Here, HOXA9 is linked to acute myeloid leukemia.